Top Breaking News | More News | Featured Stories | News By Subject | Event News | Investor News | News Archive | Search News
Get Our FREE
Industry eNewsletter
email:    

Investor News

Clinical Development News
Pre-Clinical
IND
Phase I - Safety
Phase II - Safety and Efficacy
Phase III - Controlled Safety and Efficacy
BLA/NDA/ANDA
PDUFA
Approvable Letters
Approval and Marketing Clearance
Post-Approval
Discontinued
Recalls and Warnings

Deals & Dollars News
Alliances
Earnings Reports
Financial
Investor
Mergers and Acquisitions
Start-Ups

IPO News
IPO


Biotech/Pharma - IPO
Auris Medical AG (EARS) Prices IPO At $6 A Share, Raises $56 Million 8/6/2014 7:00:36 AM
Loxo Oncology (LOXO) Prices Upsized IPO At Midpoint Of The Range, $13 A Share 8/1/2014 10:57:12 AM
Menlo Park's Avalanche Biotechnologies (AAVL) Rolls Onto Nasdaq, Raises $102 Million For Its IPO 7/31/2014 6:43:09 AM
Catalent Pharma Solutions (CTLT) Prices IPO At Midpoint Range, Raises $871 Million 7/31/2014 7:05:48 AM
BioBlast Pharma (ORPN) Prices Initial Public Offering Of $35,200,000 Of Ordinary Shares 7/31/2014 8:58:19 AM
VBL Therapeutics Announces Pricing Of Initial Public Offering 7/31/2014 9:01:40 AM
Epilepsy Biotech Marinus Pharmaceuticals (MRNS) Prices IPO At $10/Share 7/31/2014 7:35:03 AM
Israeli Biotech Macrocure Sets Terms for $75 Million IPO 7/31/2014 7:16:35 AM
Sequenom Inc. (SQNM) Announces Closing Of Initial Public Offering 7/30/2014 7:52:32 AM
Intersect ENT Announces Closing Of Its Initial Public Offering 7/30/2014 8:11:47 AM
Immune Design Corporation (IMDZ) Announces Closing Of Initial Public Offering 7/30/2014 7:42:51 AM
TherapeuticsMD, Inc.  (TXMD) Announces $40 Million Offering Of Common Stock 7/30/2014 7:14:12 AM
New York Biotech ContraFect Corporation (CFRXU) Prices Upsized IPO At $5-6 A Share 7/29/2014 6:02:34 AM
Bay Area's Intersect ENT Secures $55 Million After Hitting The Low End Of Its IPO Range 7/24/2014 11:07:52 AM
Massachusett's Ocular Therapeutix, Inc. (OCUL) Goes IPO At $13 A Share 7/25/2014 6:54:38 AM
1234567
//-->